FDA Adverse Event Malfunction Summary report: N

ALTRIX, DOMESTIC

MDR report key: 7060989 · Received November 27, 2017

Report

Report Number
0001831750-2017-00536
Event Type
Malfunction
Date Received
November 27, 2017
Date of Event
October 30, 2017
Report Date
March 29, 2018
Manufacturer
STRYKER MEDICAL-KALAMAZOO
Product Code
DWJ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

SUPPLEMENTAL SUBMITTED TO INCLUDE UDI.

Additional Manufacturer Narrative · 1

DATA FROM THE DEVICE WAS REVIEWED AND IT WAS IDENTIFIED THAT THE PATIENT TEMPERATURE HAD DEVIATED MORE THAN A DEGREE FOR MORE THAN 30 MINUTES. IT WAS IDENTIFIED THAT THIS MAY HAVE BEEN ATTRIBUTED TO THE PROBE BEING DISCONNECTED AND THEN RECONNECTED AND THEN WHEN RECONNECTED IT MAY HAVE BEEN PLACED IN A POSITION WHERE IT WAS TOUCHING THE COOLING BLANKET WHICH CAUSED THE TEMPERATURE TO READ LOW. THIS FEEDBACK WAS PROVIDED TO THE USER FACILITY. THE USER FACILITY WAS NOT ABLE TO RECALL WHAT THE CODE WAS ON THE DEVICE WHEN THIS ISSUE OCCURRED.

Description of Event or Problem · 1

IT WAS REPORTED THAT ALLEGEDLY THE USER HAS EXPERIENCED TEMPERATURE OVERSHOOT WHILE USING THE DEVICE. THE PATIENT WAS NOT AFFECTED AND NO ADVERSE CONSEQUENCE OR CLINICALLY RELEVANT DELAY IN TREATMENT WAS REPORTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT ALLEGEDLY THE USER HAS EXPERIENCED TEMPERATURE OVERSHOOT WHILE USING THE DEVICE. THE PATIENT WAS NOT AFFECTED AND NO ADVERSE CONSEQUENCE OR CLINICALLY RELEVANT DELAY IN TREATMENT WAS REPORTED.

Description of Event or Problem · 1

IT WAS REPORTED THAT ALLEGEDLY THE USER HAS EXPERIENCED TEMPERATURE OVERSHOOT WHILE USING THE DEVICE. THE PATIENT WAS NOT AFFECTED AND NO ADVERSE CONSEQUENCE OR CLINICALLY RELEVANT DELAY IN TREATMENT WAS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
840883 ALTRIX, DOMESTIC SYSTEM, THERMAL REGULATING DWJ STRYKER MEDICAL-KALAMAZOO

Patients

Seq Age Sex Outcome Treatment
1